We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

167 hedge funds and large institutions have $693M invested in Cardiovascular Systems, Inc. in 2021 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 64 increasing their positions, 50 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 50

9% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 35

2% less funds holding

Funds holding: 171167 (-4)

43% less capital invested

Capital invested by funds: $1.22B → $693M (-$528M)

Holders
167
Holders Change
-4
Holders Change %
-2.34%
% of All Funds
2.57%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
32
Increased
64
Reduced
50
Closed
35
Calls
$470K
Puts
Net Calls
+$470K
Net Calls Change
+$1.1M
Name Holding Trade Value Shares
Change
Change in
Stake
Marshall Wace
51
Marshall Wace
United Kingdom
$1.4M +$1.78M +66,492 +836%
Squarepoint
52
Squarepoint
New York
$1.3M +$1.85M +69,141 New
OQS
53
Occudo Quantitative Strategies
Florida
$1.23M +$1.31M +49,069 +301%
AG
54
Algert Global
California
$1.14M +$330K +12,360 +26%
GF
55
Gabelli Funds
New York
$1.14M -$1.37M -51,467 -46%
Victory Capital Management
56
Victory Capital Management
Texas
$1.13M +$90.1K +3,375 +6%
California State Teachers Retirement System (CalSTRS)
57
California State Teachers Retirement System (CalSTRS)
California
$1.05M +$38.9K +1,457 +3%
AllianceBernstein
58
AllianceBernstein
Tennessee
$988K +$3.26K +122 +0.2%
Barclays
59
Barclays
United Kingdom
$975K -$420K -15,737 -23%
JF
60
Jump Financial
Illinois
$927K +$1.32M +49,383 New
GI
61
GAMCO Investors
Connecticut
$884K +$198K +7,400 +19%
TI
62
Trexquant Investment
Connecticut
$884K +$1.08M +40,273 +593%
Balyasny Asset Management
63
Balyasny Asset Management
Illinois
$854K +$1.21M +45,471 New
IIM
64
Ironwood Investment Management
Massachusetts
$830K -$5.31K -199 -0.4%
BA
65
Bridgewater Associates
Connecticut
$819K +$98.2K +3,678 +9%
UBS AM
66
UBS AM
Illinois
$810K +$22.6K +847 +2%
Prudential Financial
67
Prudential Financial
New Jersey
$805K -$151K -5,657 -12%
AQR Capital Management
68
AQR Capital Management
Connecticut
$795K +$919K +34,430 +437%
Qube Research & Technologies (QRT)
69
Qube Research & Technologies (QRT)
United Kingdom
$789K +$1.12M +42,035 New
Russell Investments Group
70
Russell Investments Group
United Kingdom
$776K -$170K -6,377 -13%
DA
71
Duality Advisers
Florida
$755K +$438K +16,388 +69%
Skandinaviska Enskilda Banken (SEB)
72
Skandinaviska Enskilda Banken (SEB)
Sweden
$754K -$414K -15,500 -29%
Wells Fargo
73
Wells Fargo
California
$707K -$930K -34,837 -48%
YCM
74
Yousif Capital Management
Michigan
$696K +$990K +37,078 New
US Bancorp
75
US Bancorp
Minnesota
$679K +$35.1K +1,314 +4%

CSII Hedge Fund Activity: Q4 2021 in Review

167 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q4 2021, worth a combined $693M — down 43% from $1.22B a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of CSII and 32 opened new positions — a net loss of 3 holders — while 50 trimmed existing stakes and 64 added.

The largest buyer was Citadel Advisors, adding an estimated $14.1M. The largest seller was RGM Capital, cutting an estimated $53.3M.

  • 167 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q4 2021, down from 171 in Q3 2021.
  • Funds reported $693M of Cardiovascular Systems, Inc. stock for Q4 2021, down 43% quarter-over-quarter.
  • 32 funds opened new Cardiovascular Systems, Inc. positions in Q4 2021 and 35 closed out, a net change of -3 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q4 2021 was Citadel Advisors, an estimated $14.1M added.
  • The largest Cardiovascular Systems, Inc. seller in Q4 2021 was RGM Capital, an estimated $53.3M sold.

Based on aggregated 13F filings for Q4 2021.